Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib in Pediatric Subjects With Severe Alopecia Areata
NCT07772492Phase 3Recruiting
- Sponsor
- AbbVie Inc.
- Start
- Aug 2026
- Primary completion
- Mar 2032
- Countries
- 4
01
Overview
A Phase 3 trial of upadacitinib in alopecia areata, sponsored by AbbVie Inc.. Started Aug 2026; status: recruiting.
02
Drugs
upadacitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07772492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07772492.